11 November 2025
Livers | Highly Cited Papers in 2023–2024
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
All the articles published in Livers (ISSN: 2673-4389) are in an open access format, granting our readers free and unlimited access to the full text of every article. We welcome you to read our most highly cited papers published in 2023 and 2024.
1. “Hidden Dangers: Herbal and Dietary Supplement Induced Hepatotoxicity”
by Jonathan Kwong-Shing Lin and Shannan R. Tujios
Livers 2023, 3(4), 618-636; https://doi.org/10.3390/livers3040041
Available online: https://www.mdpi.com/2673-4389/3/4/41
2. “Mitochondria in Acetaminophen-Induced Liver Injury and Recovery: A Concise Review”
by Anup Ramachandran and Hartmut Jaeschke
Livers 2023, 3(2), 219-231; https://doi.org/10.3390/livers3020014
Available online: https://www.mdpi.com/2673-4389/3/2/14
3. “Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review”
by Karima Begriche, Clémence Penhoat, Pénélope Bernabeu-Gentey, Julie Massart and Bernard Fromenty
Livers 2023, 3(1), 33-53; https://doi.org/10.3390/livers3010003
Available online: https://www.mdpi.com/2673-4389/3/1/3
4. “The Epidemiology of Chronic Hepatitis C: Where We Are Now”
by Cristina Stasi, Caterina Milli, Fabio Voller and Caterina Silvestri
Livers 2024, 4(2), 172-181; https://doi.org/10.3390/livers4020013
Available online: https://www.mdpi.com/2673-4389/4/2/13
5. “Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex”
by Elena Gangitano, Francesca Scannapieco, Carla Lubrano and Lucio Gnessi
Livers 2024, 4(4), 534-549; https://doi.org/10.3390/livers4040038
Available online: https://www.mdpi.com/2673-4389/4/4/38
6. “Role of Mitochondrial Iron Uptake in Acetaminophen Hepatotoxicity”
by Jiangting Hu, Anna-Liisa Nieminen, Zhi Zhong and John J. Lemasters
Livers 2024, 4(3), 333-351; https://doi.org/10.3390/livers4030024
Available online: https://www.mdpi.com/2673-4389/4/3/24
7. “Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics”
by Forkan Ahamed, Natalie Eppler, Elizabeth Jones and Yuxia Zhang
Livers 2024, 4(3), 455-478; https://doi.org/10.3390/livers4030033
Available online: https://www.mdpi.com/2673-4389/4/3/33
8. “Phosphatidylcholine in Intestinal Mucus Protects against Mucosal Invasion of Microbiota and Consequent Inflammation”
by Wolfgang Stremmel and Ralf Weiskirchen
Livers 2024, 4(3), 479-494; https://doi.org/10.3390/livers4030034
Available online: https://www.mdpi.com/2673-4389/4/3/34